请参阅日本人发表的原文.下面是文摘....Hesperidin exerts hypoglycemic effects

来源: 御用文人于 2012-08-24 18:02:19 [档案] [旧帖] [给我悄悄话] 本文已被阅读：次 (8242 bytes)

本文内容已被 [ 御用文人 ] 在 2012-08-26 17:51:57 编辑过。如有问题，请报告版主或论坛管理删除.

回答: 放狗查了一下，hesperidin 只是个抗氧化剂，就是没提到有类似胰岛素功能，要知道胰岛素和降血糖药物是不一样的。由 betadine 于 2012-08-24 17:43:00

J Clin Biochem Nutr. 2010 Jan;46(1):87-92. Epub 2009 Dec 29.

Dietary hesperidin exerts hypoglycemic and hypolipidemic effects in streptozotocin-induced marginal type 1 diabetic rats.

Akiyama S, Katsumata S, Suzuki K, Ishimi Y, Wu J, Uehara M.

Source

Department of Nutritional Science, Faculty of Applied Bioscience, Tokyo University of Agriculture, Tokyo 156-8502, Japan.

Abstract

Citrus bioflavonoids may offer some protection against the early stage of diabetes mellitus and the development of complications. We investigated the effect of hesperidin on blood glucose levels, hepatic glucose-regulating enzyme activities, serum insulin and adiponectin levels, serum and hepatic lipid levels, and parameters of bone loss in streptozotocin (STZ)-induced marginal type 1 diabetic rats. Weanling male rats were randomly assigned to experimental 3 groups: a control (C) group, a STZ induced marginal type 1 diabetes (S) group, and a diabetes and hesperidin group, and fed their respective diets for 4 weeks. STZ injection increased blood glucose in rats, but the increase was marginal. Serum and hepatic lipids, serum adiponectin and insulin levels were significantly changed by STZ injection. Dietary hesperidin (10 g/kg diet) decreased blood glucose by altering the activity of glucose-regulating enzymes, and normalized the lipids and adiponectin levels, but did not change bone parameters in the marginal type 1 diabetic rats. Hesperidin showed both hypoglycemic and hypolipidemic effects but did not affect bone tissue and bone metabolic makers in STZ-injected marginal diabetic weanling rats without any body weight loss due to STZ injection.